MINNEAPOLIS, November 19, 2024 — Today Ōmcare announced the appointment of Martha Goldberg Aronson to its Board of Directors. Martha is a distinguished healthcare industry leader with over 25 years of experience who brings extensive expertise in scaling medical device businesses.
“Martha’s appointment to our board comes at a critical inflection point for Ōmcare as we prepare to scale,” said Lisa Lavin, CEO of Ōmcare. “Martha’s proven ability to guide companies through rapid expansion while maintaining operational excellence makes her an ideal addition to our board. We look forward to benefiting from Martha’s leadership and expertise as we continue to revolutionize medication adherence and remote care delivery.”
Ms. Goldberg Aronson currently serves as Chair of the Board for ConMed Corporation and comes with extensive board experience in medical technology. She has held executive leadership positions at several leading healthcare companies including Medtronic, Hill-Rom and Ecolab. During her tenure at Medtronic, she led the business unit that successfully launched the InterStim sacral neuromodulation device, demonstrating her ability to bring innovative medical technologies to market and scale operations effectively.
“I’m honored to join Ōmcare’s Board of Directors at this important juncture,” said Ms. Goldberg Aronson. “As our population continues to age, medication non-adherence and our caregiver shortage become even more pressing challenges. Ōmcare’s innovative technology platform addresses these critical issues and supports an individual’s wellness and independence. I look forward to working alongside the board and management team to help scale this transformative platform and create meaningful impact for healthcare providers, patients, and their families.”